These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1861638)
21. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Barnabei VM; Grady D; Stovall DW; Cauley JA; Lin F; Stuenkel CA; Stefanick ML; Pickar JH Obstet Gynecol; 2002 Dec; 100(6):1209-18. PubMed ID: 12468165 [TBL] [Abstract][Full Text] [Related]
22. Oestrogen replacement therapy and cardiovascular disease in post-menopausal women. A review. Sitruk-Ware R; Ibarra de Palacios P Maturitas; 1989 Dec; 11(4):259-74. PubMed ID: 2693914 [TBL] [Abstract][Full Text] [Related]
23. Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis. Grey AB; Cundy TF; Reid IR Clin Endocrinol (Oxf); 1994 May; 40(5):671-7. PubMed ID: 8013147 [TBL] [Abstract][Full Text] [Related]
24. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study. Helle SI; Omsjø IH; Hughes SC; Botta L; Hüls G; Holly JM; Lønning PE Clin Endocrinol (Oxf); 1996 Dec; 45(6):727-32. PubMed ID: 9039339 [TBL] [Abstract][Full Text] [Related]
25. The significance of oestriol in the management of the post-menopause. Tzingounis VA; Aksu MF; Greenblatt RB Acta Endocrinol Suppl (Copenh); 1980; 233():45-50. PubMed ID: 6773286 [TBL] [Abstract][Full Text] [Related]
26. Bazedoxifene for HRT? Drug Ther Bull; 2017 Apr; 55(4):42-44. PubMed ID: 28408389 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial. Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965 [TBL] [Abstract][Full Text] [Related]
28. Mood scores in relation to hormone replacement therapies during menopause: a prospective randomized trial. Onalan G; Onalan R; Selam B; Akar M; Gunenc Z; Topcuoglu A Tohoku J Exp Med; 2005 Nov; 207(3):223-31. PubMed ID: 16210834 [TBL] [Abstract][Full Text] [Related]
29. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Norman RJ; Flight IH; Rees MC Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730 [TBL] [Abstract][Full Text] [Related]
30. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate. Lemay A; Dodin S; Cédrin I; T-Lemay L Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187 [TBL] [Abstract][Full Text] [Related]
31. Estradiol and norgestimate: a review of their combined use as hormone replacement therapy in postmenopausal women. Curran MP; Wagstaff AJ Drugs Aging; 2001; 18(11):863-85. PubMed ID: 11772126 [TBL] [Abstract][Full Text] [Related]
32. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3. Deleruyelle LJ Int J Pharm Compd; 2017; 21(1):6-16. PubMed ID: 28346192 [TBL] [Abstract][Full Text] [Related]
33. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2. Deleruyelle LJ Int J Pharm Compd; 2016; 20(6):447-454. PubMed ID: 28339382 [TBL] [Abstract][Full Text] [Related]
34. Dry eye in post-menopausal women using hormone replacement therapy. Erdem U; Ozdegirmenci O; Sobaci E; Sobaci G; Göktolga U; Dagli S Maturitas; 2007 Mar; 56(3):257-62. PubMed ID: 17030104 [TBL] [Abstract][Full Text] [Related]
35. [Treating menopause syndrome by kuntal capsule and hormone replacement therapy: a meta-analysis of efficacy and safety comparison]. Li CC; Wang JJ; Chen C; Li YF; Zheng QS; Yang J; Liu HX Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Sep; 33(9):1183-90. PubMed ID: 24273970 [TBL] [Abstract][Full Text] [Related]
36. [Towards an optimization of the modulation of the estrogen receptor during menopausal hormonal therapy]. Valéra MC; Fontaine C; Noirrit-Esclassan E; Boudou F; Buscato M; Adlanmerini M; Trémollières F; Gourdy P; Lenfant F; Arnal JF Med Sci (Paris); 2018 Dec; 34(12):1056-1062. PubMed ID: 30623764 [TBL] [Abstract][Full Text] [Related]
37. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg. Johansen OE; Qvigstad E Adv Ther; 2008 Jun; 25(6):525-51. PubMed ID: 18568306 [TBL] [Abstract][Full Text] [Related]
38. Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy. Mattsson LÅ; Ipsen HE; Granqvist CJ; Kokot-Kierepa M; Climacteric; 2015 Jun; 18(3):419-25. PubMed ID: 25603163 [TBL] [Abstract][Full Text] [Related]
39. The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial. Carmignani LO; Pedro AO; Costa-Paiva LH; Pinto-Neto AM Maturitas; 2010 Nov; 67(3):262-9. PubMed ID: 20833488 [TBL] [Abstract][Full Text] [Related]